EQL Pharma is a generics- and speciality pharma company, dedicated to providing cost efficient pharmaceuticals for the Nordic markets. This is accomplished with the highest quality standards and streamlined logistic solutions.
EQL Pharma"s first hospital product approved
The pharmaceutical Hevicain Spinal Tung 5mg / ml solution for injection has been approved for sale by the Swedish and Danish pharmaceutical authorities. It is expected to soon be approved by the authorities in Norway and Finland as well.
Kommuniké från årsstämma i EQL Pharma AB (publ) den 22 augusti 2019
Vid EQL Pharmas årsstämma, som hölls i Lund idag den 22 augusti 2019, fattades följande beslut:
- View all press releases